EMC Capital Management Has $190,000 Position in Astera Labs, Inc. $ALAB

EMC Capital Management lessened its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 40.0% during the 2nd quarter, HoldingsChannel reports. The firm owned 2,100 shares of the company’s stock after selling 1,400 shares during the quarter. EMC Capital Management’s holdings in Astera Labs were worth $190,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Oliver Lagore Vanvalin Investment Group acquired a new stake in shares of Astera Labs in the second quarter worth $29,000. Bernard Wealth Management Corp. bought a new position in Astera Labs in the 2nd quarter worth $36,000. Clearstead Trust LLC lifted its position in Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after acquiring an additional 461 shares during the last quarter. Harbour Investments Inc. boosted its holdings in Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock valued at $47,000 after acquiring an additional 619 shares during the period. Finally, Hazlett Burt & Watson Inc. grew its position in shares of Astera Labs by 1,670.0% in the first quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company’s stock valued at $53,000 after purchasing an additional 835 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Activity

In other news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the sale, the director directly owned 385,863 shares in the company, valued at approximately $66,858,482.01. The trade was a 32.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jack R. Lazar sold 22,500 shares of the stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the completion of the transaction, the director directly owned 97,351 shares of the company’s stock, valued at $17,369,365.42. This trade represents a 18.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 225,500 shares of company stock worth $39,531,460. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Trading Down 1.3%

Shares of ALAB stock opened at $139.52 on Wednesday. The stock has a 50 day moving average of $190.50 and a two-hundred day moving average of $145.33. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The company has a market capitalization of $23.56 billion, a P/E ratio of 125.69, a P/E/G ratio of 2.64 and a beta of 1.37.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.Astera Labs’s quarterly revenue was up 103.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the topic of a number of recent analyst reports. Barclays reiterated an “equal weight” rating and issued a $155.00 price objective on shares of Astera Labs in a research note on Monday, October 20th. TD Cowen dropped their price target on Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a research report on Wednesday, November 5th. Cowen reiterated a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. Evercore ISI raised their price objective on shares of Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 6th. Finally, Stifel Nicolaus boosted their target price on shares of Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $184.82.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.